Development of Recombinant Measles Virus-Based Vaccines

This chapter describes the development of recombinant measles virus (MV)-based vaccines starting from plasmid DNA. Live-attenuated measles vaccines are very efficient and safe. Since the availability of a reverse genetic system to manipulate MV genomes and to generate respective recombinant viruses,...

Descripción completa

Detalles Bibliográficos
Autores principales: Mühlebach, Michael D., Hutzler, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121886/
https://www.ncbi.nlm.nih.gov/pubmed/28374248
http://dx.doi.org/10.1007/978-1-4939-6869-5_9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121886/
https://www.ncbi.nlm.nih.gov/pubmed/28374248
http://dx.doi.org/10.1007/978-1-4939-6869-5_9

Ejemplares similares